title: Controlled-release formulation of antihistamine based on cetirizine zinc-layered hydroxide nanocomposites and its effect on histamine release from basophilic leukemia (RBL-2H3) cells.
abstract: A controlled-release formulation of an antihistamine, cetirizine, was synthesized using zinc-layered hydroxide as the host and cetirizine as the guest. The resulting well-ordered nanolayered structure, a cetirizine nanocomposite "CETN," had a basal spacing of 33.9 Å, averaged from six harmonics observed from X-ray diffraction. The guest, cetirizine, was arranged in a horizontal bilayer between the zinc-layered hydroxide (ZLH) inorganic interlayers. Fourier transform infrared spectroscopy studies indicated that the intercalation takes place without major change in the structure of the guest and that the thermal stability of the guest in the nanocomposites is markedly enhanced. The loading of the guest in the nanocomposites was estimated to be about 49.4% (w/w). The release study showed that about 96% of the guest could be released in 80 hours by phosphate buffer solution at pH 7.4 compared with about 97% in 73 hours at pH 4.8. It was found that release was governed by pseudo-second order kinetics. Release of histamine from rat basophilic leukemia cells was found to be more sensitive to the intercalated cetirizine in the CETN compared with its free counterpart, with inhibition of 56% and 29%, respectively, at 62.5 ng/mL. The cytotoxicity assay toward Chang liver cells line show the IC₅₀ for CETN and ZLH are 617 and 670 μg/mL, respectively.
authors: Department of Chemistry, Faculty of Science, Universiti Putra, Malaysia.
authors: Samer
authors: S
authors: Hasan
authors: Hussein
authors: H
authors: Al Ali
authors: Mothanna
authors: M
authors: Al-Qubaisi
authors: Mohd
authors: M
authors: Zobir Hussein
authors: Maznah
authors: M
authors: Ismail
authors: Zulkarnain
authors: Z
authors: Zainal
authors: Muhammad
authors: M
authors: Nazrul Hakim
mesh_terms: D000327:Adsorption; D000818:Animals; D016923:Cell Death / Q000187:drug effects; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000187:drug effects; D017332:Cetirizine / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics; D003692:Delayed-Action Preparations; D039563:Histamine H1 Antagonists, Non-Sedating / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics; D006636:Histamine Release / Q000187:drug effects*; D006863:Hydrogen-Ion Concentration; D006878:Hydroxides / Q000737:chemistry*; D015471:Leukemia, Basophilic, Acute / Q000378:metabolism*; D053761:Nanocomposites / Q000737:chemistry*; D033362:Powder Diffraction; D051381:Rats; D017550:Spectroscopy, Fourier Transform Infrared; D013499:Surface Properties; D013818:Thermogravimetry; D017967:Zinc Compounds / Q000737:chemistry*
chemical_list: D003692:Delayed-Action Preparations; D039563:Histamine H1 Antagonists, Non-Sedating; D006878:Hydroxides; D017967:Zinc Compounds; C052745:zinc hydroxide; D017332:Cetirizine